Article thumbnail

Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis

By Deepti Malhotra, Elodie Portales-Casamar, Anju Singh, Siddhartha Srivastava, David Arenillas, Christine Happel, Casper Shyr, Nobunao Wakabayashi, Thomas W. Kensler, Wyeth W. Wasserman and Shyam Biswal

Abstract

The Nrf2 (nuclear factor E2 p45-related factor 2) transcription factor responds to diverse oxidative and electrophilic environmental stresses by circumventing repression by Keap1, translocating to the nucleus, and activating cytoprotective genes. Nrf2 responses provide protection against chemical carcinogenesis, chronic inflammation, neurodegeneration, emphysema, asthma and sepsis in murine models. Nrf2 regulates the expression of a plethora of genes that detoxify oxidants and electrophiles and repair or remove damaged macromolecules, such as through proteasomal processing. However, many direct targets of Nrf2 remain undefined. Here, mouse embryonic fibroblasts (MEF) with either constitutive nuclear accumulation (Keap1−/−) or depletion (Nrf2−/−) of Nrf2 were utilized to perform chromatin-immunoprecipitation with parallel sequencing (ChIP-Seq) and global transcription profiling. This unique Nrf2 ChIP-Seq dataset is highly enriched for Nrf2-binding motifs. Integrating ChIP-Seq and microarray analyses, we identified 645 basal and 654 inducible direct targets of Nrf2, with 244 genes at the intersection. Modulated pathways in stress response and cell proliferation distinguish the inducible and basal programs. Results were confirmed in an in vivo stress model of cigarette smoke-exposed mice. This study reveals global circuitry of the Nrf2 stress response emphasizing Nrf2 as a central node in cell survival response

Topics: Genomics
Publisher: Oxford University Press
OAI identifier: oai:pubmedcentral.nih.gov:2943601
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2008). Activation of Nrf2-antioxidant signaling attenuates NFkappaB-inflammatory response and elicits apoptosis.
  2. (2009). Age-accelerated atherosclerosis correlates with failure to upregulate antioxidant genes.
  3. (2008). Altered Nrf2/Keap1-Bach1 equilibrium in pulmonary emphysema.
  4. and Biswal,S.(2006) Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis
  5. and Reddy,S.P.(2008) Genetic disruption of the Nrf2 compromises cell-cycle progression by impairing GSH-induced redox signaling.
  6. (2004). Applied bioinformatics for the identification of regulatory elements.
  7. (2005). Assessing computational tools for the discovery of transcription factor binding sites.
  8. (2004). Bioconductor: open software development for computational biology and bioinformatics.
  9. (2009). Carnosic acid and carnosol inhibit adipocyte differentiation in mouse 3T3-L1 cells through induction of phase2 enzymes and activation of glutathione metabolism.
  10. (2007). Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway.
  11. (1995). Cloning and characterization of a novel erythroid cell-derived CNC family transcription factor heterodimerizing with the small Maf family proteins.
  12. (2005). Comparison of (-)-epigallocatechin-3-gallate elicited liver and small intestine gene expression profiles between C57BL/6J mice and C57BL/6J/Nrf2 (-/-) mice.
  13. (2008). Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1.
  14. (2005). Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice.
  15. (2008). Down-regulated NF-E2-related factor 2 in pulmonary macrophages of aged smokers and patients with chronic obstructive pulmonary disease.
  16. (2006). Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer.
  17. (2003). Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.
  18. (2008). FindPeaks 3.1: a tool for identifying areas of enrichment from massively parallel short-read sequencing technology.
  19. (1994). Fitting a mixture model by expectation maximization to discover motifs in biopolymers.
  20. (2006). Gene expression profiles induced by cancer chemopreventive isothiocyanate sulforaphane in the liver of C57BL/6J mice and C57BL/6J/Nrf2 (-/-) mice.
  21. (2004). Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice.
  22. (2007). Genetic dissection of the Nrf2-dependent redox signaling-regulated transcriptional programs of cell proliferation and cytoprotection.
  23. (2005). Genetic evidence that small maf proteins are essential for the activation of antioxidant response element-dependent genes.
  24. (2008). Genetic or pharmacologic amplification of nrf2 signaling inhibits acute inflammatory liver injury in mice.
  25. (2007). Genome-wide profiles of STAT1 DNA association using chromatin immunoprecipitation and massively parallel sequencing.
  26. (2006). Glutathione peroxidase 2, the major cigarette smoke-inducible isoform of GPX in lungs, is regulated by Nrf2.
  27. (2009). Heightened endoplasmic reticulum stress in the lungs of patients with chronic obstructive pulmonary disease: the role of Nrf2-regulated proteasomal activity.
  28. (2006). Hepatocyte-specific deletion of the keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity.
  29. (2003). Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary
  30. (2009). Impact of chromatin structures on DNA processing for genomic analyses.
  31. (2006). Increased expression of nuclear factor E2 p45-related factor 2 (NRF2) in head and neck squamous cell carcinomas.
  32. (2007). Induction of antioxidant and detoxification response by oxidants in cardiomyocytes: evidence from gene expression profiling and activation of Nrf2 transcription factor.
  33. (2008). JASPAR, the open access database of transcription factor-binding profiles: new content and tools in the 2008 update.
  34. (2007). Keap1 controls postinduction repression of the Nrf2-mediated antioxidant response by escorting nuclear export of Nrf2.
  35. (2003). Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation.
  36. (2007). Mapping of transcription factor binding regions in mammalian cells by ChIP: comparison of array- and sequencing-based technologies.
  37. (2003). Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival.
  38. (2004). NADPH oxidase and ERK signaling regulates hyperoxia-induced Nrf2-ARE transcriptional response in pulmonary epithelial cells.
  39. (2009). Nrf2 activity is lost in the spinal cord and its astrocytes of aged mice.
  40. (2006). Nrf2 defends the lung from oxidative stress.
  41. (1999). Nrf2 is essential for protection against acute pulmonary injury in mice.
  42. (2007). NRF2 modulates aryl hydrocarbon receptor signaling: influence on adipogenesis.
  43. (2006). Nrf2 negatively regulates osteoblast differentiation via interfering with Runx2-dependent transcriptional activation.
  44. (2009). Nrf2-regulated glutathione recycling independent of biosynthesis is critical for cell survival during oxidative stress. Free Radic.
  45. (2005). Nrf2, a multi-organ protector?
  46. (2007). Nrf2/ARE regulated antioxidant gene expression in endothelial and smooth muscle cells in oxidative stress: implications for atherosclerosis and preeclampsia.
  47. (2005). oPOSSUM: identification of over-represented transcription factor binding sites in co-expressed genes.
  48. (2007). PAZAR: a framework for collection and dissemination of cis-regulatory sequence annotation.
  49. (2008). Physiological significance of reactive cysteine residues of
  50. (2008). RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy.
  51. (2002). Role of NRF2 in protection against hyperoxic lung injury in mice.
  52. (2007). Role of Nrf2 in protection against intracerebral hemorrhage injury in mice. Free Radic.
  53. (1990). Sequence logos: a new way to display consensus sequences.
  54. (2001). Significance analysis of microarrays applied to the ionizing radiation response.
  55. (2008). Small Maf proteins in mammalian gene control: mere dimerization partners or dynamic transcriptional regulators?
  56. (2003). Soluble VEGF receptor Flt1: the elusive preeclampsia factor discovered?
  57. (2009). Synthetic triterpenoids attenuate cytotoxic retinal injury: cross-talk between Nrf2 and PI3K/AKT signaling through inhibition of the lipid phosphatase PTEN.
  58. (2009). Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.
  59. (2009). Targeting Nrf2 with the triterpenoid CDDO-imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice.
  60. (2002). TFBS: Computational framework for transcription factor binding site analysis.
  61. (1992). Two adjacent AP-1-like binding sites form the electrophile-responsive element of the murine glutathione S-transferase Ya subunit gene.